Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Post by theinvestor22on Jun 02, 2023 10:08pm
269 Views
Post# 35478074

Price/Revenue Multiple

Price/Revenue Multiple
I posted something like this a while ago.  Here's an update which compares just fiscal Q3s (using basic shares):
 
When Q3 f2021 results were announced, the price/revenue multiple was about $0.55 stock price / ($442k rev x 4 Qs / 163,342 sh) = 50.8
 
When Q3 f2022 results were announced, the price/revenue multiple was about $0.55 stock price / ($2,515k rev x 4 Qs / 186,284 sh) = 10.2
 
At the present time (after Q3 f2023 results were announced) the current price/revenue multiple is about $0.53 stock price / ($4,741 rev x 4 Qs / 194,630 sh) = 5.4
 
So, at some point, the price/revenue multiple should bottom out, then reverse course as revenue continues to increase, profit grows and collections happen.  I'm not a price guy, so I'm not going to opine as to when the reversal will occur, but I'm quite confident it is a highly likely event.
<< Previous
Bullboard Posts
Next >>